| ¿µ¹® | aging, senescence | ÇÑ±Û | ³ëÈ, ´ÄÀ½ |
|---|---|---|---|
| ¼³¸í | ³ªÀÌ ¸Ô´Â´Ù´Â Àǹ̷Π»ç¿ëµÇ±âµµ ÇÏÁö¸¸ ÀϹÝÀûÀ¸·Î´Â ¼ºÀåÀÌ ¿Ï·á, Á¤ÁöµÇ°í ±× ÀÌÈÄ¿¡ ÀϾ´Â ¸ðµç °úÁ¤À» °¡¸®Å²´Ù. ³ªÀ̸¦ ¸Ô¾î°¨¿¡ µû¶ó »ýüÀÇ ¿©·¯ °¡Áö ±â´ÉÀÌ ÀúÇϵǴµ¥, ÀϹÝÀûÀ¸·Î ¼¼Æ÷¿¡ »ö¼Ò°¡ ÃàÀûµÇ°Å³ª ¼¼Æ÷ÀÚü³ª ÇÙÀÌ ÀÛ¾ÆÁö´Â Çö»óÀÌ´Ù. °³°³ÀÇ ¼¼Æ÷ ±â´Éµµ ÀúÇϵǰí, ¼¼Æ÷ ³»¿¡ »ö¼Ò°¡ Ä§ÂøµÇ¸ç, ±â°üÀº ¾Ï°¥»öÀ» ¶í´Ù. ¶ÇÇÑ ÇǺδ ¾ã¾ÆÁö°í ÅÐÁָӴϵµ À§ÃàµÇ¸ç, ¸ð¹ßÀº »ö¼Ò¸¦ ÀÒ°í Å»¸ðµÈ´Ù. ÇöÀç ¸¹Àº ÇÐÀÚµéÀº ¼¼Æ÷³» DNA°¡ ²÷¾îÁö°Å³ª ²÷¾îÁø °æ¿ì ¼öº¹·ÂÀÌ °¨¼ÒÇϰųª, ¸é¿ª·ÂÀÌ ÀúÇÏÇϱ⠶§¹®À¸·Î º¸°í ÀÖ´Ù. ³ëȰ¡ ÀϾ´Â °ÍÀº ¼¼Æ÷ÀÇ Á¾·ù¿¡ µû¶ó¼ Å©°Ô ´Ù¸¥µ¥ ½Å°æ¼¼Æ÷ó·³ Å¾¼ Á×À» ¶§±îÁö ¼¼Æ÷ºÐ¿ÇÏÁö ¾Ê´Â ¼¼Æ÷´Â ³ëȰ¡ µÎµå·¯Áö°í °íȯÀ̳ª °ñ¼öÀÇ ¼¼Æ÷ó·³ Ç×»ó ºÐ¿ÇÏ´Â ¼¼Æ÷´Â ³ëÈÇö»óÀÌ °ÅÀÇ ÀϾÁö ¾Ê´Â´Ù. ¹ßº´°ú Á×À½ÀÇ È®·üÀÌ ³ô¾ÆÁöÁö¸¸, ³ë¼è¼º º¯È¿Í º´Àû º¯È¿ÍÀÇ °æÁ¦´Â ¸íÈ®ÇÏÁö ¾Ê´Ù. ³ë¼è¸¦ ¾ß±âÇÏ´Â ³ëÈÀÇ º»ÁúÀû ¿øÀο¡ ´ëÇØ¼´Â ¾ÆÁ÷ Á¤¼³ÀÌ ¾ø´Ù. |
||
| ¿µ¹® | Dilatation and Curettage(D & C) | ÇÑ±Û | Àڱñܾ¼ú, ÀڱøñÈ®Àå |
|---|---|---|---|
| ¼³¸í | ÀÚ±ÃÀ̶õ žư¡ ¼öÅÂµÇ¾î¼ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇÏ´Â °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ žƸ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇÏ´Â ÀڱøñÀ» È®Àå½ÃÄÑ¾ß ÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇÏ´Â ¹ý°ú ¼¼È÷ È®ÀåÀ» ½ÃµµÇÏ´Â 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ ÀÖ¾î¼ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼¼È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇÏ´Â ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃÊ·Î ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î õõÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼ ÀڱüÓÀÇ º´º¯À̳ª ÀÓ½ÅµÈ Å¾Ƹ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀÇ Ã¤Ãë ¹× Á¦°Å¸¦ À§Çؼµµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. ÀÌ´Â ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà ³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù. |
||
| ¿µ¹® | physical examination | ÇÑ±Û | ÁøÂû, ½Åü°Ë»ç |
|---|---|---|---|
| ¼³¸í | 1. Áúº´ÀÇ Áø´Ü¼ö´ÜÀ¸·Î¼ ȯÀÚÀÇ ¸öÀ» º¸´Â Áø´Ü. ¸¸Áö´Â Áø´Ü, µÎµå¸®´Â Áø´Ü, µè´Â Áø´Ü µîÀ» ÅëÇÏ¿© °Ë»çÇÏ´Â °Í. ½Åü°Ë»ç. 2. °Ç°»óŸ¦ ¾Ë±â À§ÇÏ¿© ½ÅüÀÇ °¢ ºÎºÐÀ» °Ë»çÇÏ´Â ÀÏ ¶Ç´Â ¹ý¿øÀÇ ½Åü¿¡ ´ëÇÑ Áõ°Å Á¶»ç. ÀϹÝÀûÀ¸·Î´Â ÈçÈ÷ ¼ÒÁöǰÀÇ °Ë»ç¶ó´Â ¶æÀ¸·Îµµ ¾²ÀδÙ. ¨è Çб³º¸°Ç¹ý»ó : ÇлýµéÀÇ Ã¼°Ý°Ë»ç-üÁú°Ë»ç-ü´É°Ë»ç¸¦ ¸»ÇÑ´Ù(2Á¶). Çб³ÀÇ ÀåÀº ÇØ¸¶´Ù Çлý°ú ±³Á÷¿øÀÇ ½Åü°Ë»ç¸¦ ÇØ¾ß ÇÑ´Ù. ´Ù¸¸ ±³Á÷¿ø¿¡ ´ëÇÑ ½Åü°Ë»ç´Â ¡®°ø¹«¿ø ¹× »ç¸³Çб³±³Á÷¿ø ÀǷẸÇè¹ý¡¯¿¡ ÀÇÇÑ °Ç°Áø´ÜÀ¸·Î ÀÌ¿¡ °¥À½ÇÒ ¼ö ÀÖ´Ù. ½Åü°Ë»ç½Ç½ÃÀÇ ½Ã±â-¹æ¹ý-ÀýÂ÷ µîÀº ±³À°ºÎ·ÉÀ¸·Î Á¤ÇÑ´Ù(7Á¶). Çб³ÀÇ ÀåÀº ½Åü°Ë»çÀÇ °á°ú Àü¿°º´¿¡ °¨¿°µÇ¾ú°Å³ª, °¨¿°µÇ¾ú´Ù´Â ÇøÀǰ¡ Àְųª °¨¿°µÉ ¿ì·Á°¡ ÀÖ´Â ÀÚÀÇ µî±³¸¦ ÁßÁö½Ãų ¼ö ÀÖ´Ù(8Á¶). ¨è Çü»ç¼Ò¼Û¹ý»ó : ¹ý¿øÀÌ Áõ°ÅÀڷḦ ¾ò±â À§ÇÏ¿© ½Åü¸¦ °ËÁõÇÏ´Â °ÍÀ» ¶æÇÑ´Ù. ¹ý¿øÀº »ç½Ç¹ß°ß¿¡ ÇÊ¿äÇÏ¸é ½Åü°Ë»ç¸¦ ÇÒ ¼ö ÀÖ°í(140Á¶), °¨Á¤ÀÎ ¹× ¼ö»ç±â°üµµ ½Åü°Ë»ç¸¦ ÇÒ ¼ö ÀÖ´Ù(173-219Á¶). ½Åü°Ë»ç´Â °Ë»ç¸¦ ´çÇÏ´Â ÀÚÀÇ ¼ºº°-¿¬·É-°Ç°»óÅ ±âŸ »çÁ¤À» °í·ÁÇÏ¿©, ±× »ç¶÷ÀÇ °Ç°°ú ¸í¿¹¸¦ ÇØÇÏÁö ¾Æ´ÏÇϵµ·Ï ÁÖÀÇÇÏ¿©¾ß ÇÑ´Ù. ¿©ÀÚÀÇ ½Åü °Ë»ç¸¦ ÇÒ ¶§¿¡´Â Àǻ糪 ¼º³âÀÇ ¿©ÀÚ¸¦ Âü¿©½ÃÄÑ¾ß ÇÑ´Ù(141Á¶). ¹ý¿øÀº ½Åü °Ë»ç¸¦ Çϱâ À§ÇÏ¿©, ÇǰíÀÎÀÌ ¾Æ´Ñ ÀÚ¸¦ ¹ý¿ø ±âŸÀÇ ÁöÁ¤ÇÑ Àå¼Ò¿¡ ¼ÒȯÇÒ ¼ö ÀÖ´Ù(142Á¶). |
||
| NYHA | New York Heart Association Heart Disease¿¡ ´ëÇÑ Functional Classification &nbs... |
|---|---|
| PE | Edinburgh Pharmacopoeia; pancreatic extract; paper electrophoresis; partial epilepsy; pelvic examina... |
| PT | pain threshold; parathormone; parathyroid; paroxysmal tachycardia; part time; patient; pericardial t... |
| PAR | participating provider; passive avoidance reaction; perennial allergic rhinitis; photosynthetically ... |
| NCA | National Certification Agency; National Council on Aging; National Council on Alcoholism; neurocircu... |
| CSHA | Canadian Study of Health and Aging |
|---|---|
| JAMA | Journal of the American Medical Association |
| NEJM | New England Journal of Medicine |
| LTPA | Leisure Time Physical Activity |
| PAI | Physical Activity Index |
| journal article | The predominant publication type for articles and other items indexed for nlm databases. (12 Dec 1998) |
|---|---|
| physical education and training | Instructional programs in the care and development of the body, often in schools. The concept does not include prescribed exercises, which is exercise therapy. (12 Dec 1998) |
| aging | The gradual changes in the structure and function of humans and animals that occur with the passage of time, that do not result from disease or other gross accidents, and that eventually lead to the increased probability of death as the person or animal grows older. It does not apply to microorganisms. (12 Dec 1998) |
| aging, premature | Changes in the organism associated with senescence, occurring at an accelerated rate. (12 Dec 1998) |
| cell aging | The decrease in the cell's ability to proliferate with the passing of time. Each cell is programmed for a certain number of cell divisions and at the end of that time proliferation halts. The cell enters a quiescent state after which it experiences cell death via the process of apoptosis. (12 Dec 1998) |
| clonal aging | The deterioration in successive generations of a clone; thus paramecia and other simple forms, if allowed to reproduce asexually for a number of generations, invariably undergo deterioration, the characters of each group of descendants progressively departing from those of the original sexually produced ancestor. (05 Mar 2000) |
| skin aging | The process of aging due to changes in the structure and elasticity of the skin over time. It may be a part of physiological aging or it may be due to the effects of ultraviolet radiation, usually through exposure to sunlight. (12 Dec 1998) |
| erythrocyte aging | Senescence of the red blood cell. Lacking the organelles that make protein synthesis possible, the mature erythrocyte is incapable of self-repair, reproduction, and carrying out certain functions performed by other cells. This limits the average life span of an erythrocyte to 120 days. (12 Dec 1998) |
| activity | 1. The state of being active, the ability to produce some effect, the extent of some function or action. 2. <chemistry> A thermodynamic quantity that represents the effective concentration of a solute in a nonideal solution, if concentrations are replaced by activities, the equations for equilibrium constants, electrode potentials, osmotic pressure, boiling point elevation, freezing point depression and vapour pressures of volatile solutes are converted from approximations that hold only for dilute solutions to exact equations that hold for all concentrations. The activity is equal to the product of the concentration and the activity coefficient, a dimensionless number measuring deviation from nonideality. Symbol a. The potential or true thermodynamic activity of a substance, as opposed to its molar concentration. 3. <radiobiology> The number of nuclear transitions or disintegrations occurring in a given quantity of radioactive material per unit time. The SI unit of activity is s-1. The special name for the unit of activity is becquerel (Bq). The previously used special unit of activity, curie (Ci), is being replaced by the becquerel. 1 Bq = 2.7 x E-11 Ci. 1 Ci = 3.7 x E10 Bq. 4. Optical activity. (16 Dec 1997) |
| activity coefficient | <chemistry> The factor by which the value of a concentration of a solute must be multiplied to determine its true thermodynamic activity. (06 May 1997) |
| activity cycles | Bouts of physical irritability or movement alternating with periods of quiescence. It includes biochemical activity and hormonal activity which may be cellular. These cycles are shorter than 24 hours and include sleep-wakefulness cycles and the periodic activation of the digestive system. (12 Dec 1998) |
| activity, drug | A measure of the physiological response a drug produces in the body. A less active drug produces less response (and visa versa). (12 Dec 1998) |
| blocking activity | The repression or elimination of electrical activity in the brain by the arrival of a sensory stimulus. (05 Mar 2000) |
| blood bactericidal activity | Native bactericidal property of blood due to normally occurring antibacterial substances such as beta lysin, leukin, etc. (12 Dec 1998) |
| melanoma growth stimulatory activity | Cytokine of the C X C subfamily. Potent mitogen. Activates and is chemotactic for, neutrophils. (18 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|